Cargando…

Network meta‐analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction

BACKGROUND: Following the availability of new drugs for chronic heart failure (HF) with reduced ejection fraction (HFrEF), we sought to provide an updated and comparative synthesis of the evidence on HFrEF pharmacotherapy efficacy. METHODS: We performed a Bayesian network meta‐analysis of phase 2 an...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Marzo, Vincenzo, Savarese, Gianluigi, Tricarico, Lucia, Hassan, Sofia, Iacoviello, Massimo, Porto, Italo, Ameri, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546056/ https://www.ncbi.nlm.nih.gov/pubmed/35332595 http://dx.doi.org/10.1111/joim.13487

Ejemplares similares

The National Medical Union and the £90,000 to Panel Doctors
por: Greenyer, Vivian T.
Publicado: (1914)

A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women
por: Wang, Xiaoliang, et al.
Publicado: (2022)

Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births
por: Iafusco, D., et al.
Publicado: (2011)

90,000 year-old specialised bone technology in the Aterian Middle Stone Age of North Africa
por: Bouzouggar, Abdeljalil, et al.
Publicado: (2018)

A worked bone assemblage from 120,000–90,000 year old deposits at Contrebandiers Cave, Atlantic Coast, Morocco
por: Hallett, Emily Y., et al.
Publicado: (2021)

Outcome of care in an apex tertiary care referral institute of North India – A study of 90,000 patients
por: Mirza, Moonis, et al.
Publicado: (2020)

Lipoprotein-Associated Phospholipase A(2) Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults
por: Millwood, Iona Y., et al.
Publicado: (2016)

Contacts in the last 90,000 years over the Strait of Gibraltar evidenced by genetic analysis of wild boar (Sus scrofa)
por: Soria-Boix, Carmen, et al.
Publicado: (2017)

Efficacy and Safety of 90,000 IU versus 300,000 IU Single Dose Oral Vitamin D in Nutritional Rickets: A Randomized Controlled Trial
por: Mittal, Medha, et al.
Publicado: (2018)

Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody
Publicado: (1984)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction
por: Stolfo, Davide, et al.
Publicado: (2022)

Mixing of components from different manufacturers in total hip arthroplasty: prevalence and comparative outcomes: A study of over 90,000 cases of mixed components in the National Joint Registry for England and Wales
por: Tucker, Keith, et al.
Publicado: (2015)

Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies
por: Zhang, Chi, et al.
Publicado: (2018)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Stolfo, Davide, et al.
Publicado: (2019)

Sacubitril/valsartan in real‐life European patients with heart failure and reduced ejection fraction: a systematic review and meta‐analysis
por: Giovinazzo, Stefano, et al.
Publicado: (2021)

Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction
por: Kapelios, Chris J, et al.
Publicado: (2023)

Temporal trends in evidence supporting therapeutic interventions in heart failure and other European Society of Cardiology guidelines
por: Canepa, Marco, et al.
Publicado: (2023)

Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction
por: Stolfo, Davide, et al.
Publicado: (2023)

Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem
por: Upadhya, Bharathi, et al.
Publicado: (2015)

Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction
por: Löfström, Ulrika, et al.
Publicado: (2019)

Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting
por: Stolfo, Davide, et al.
Publicado: (2022)

The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2020)

A registry‐based algorithm to predict ejection fraction in patients with heart failure
por: Uijl, Alicia, et al.
Publicado: (2020)

Left ventricular contractile performance and heart failure in patients with left ventricular ejection fraction more than 40%
por: Kitada, Shuichi, et al.
Publicado: (2020)

Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes
por: Gevaert, Andreas B., et al.
Publicado: (2021)

Effect of Stent Inflation Pressure and Post-Dilatation on the Outcome of Coronary Artery Intervention. A Report of More than 90 000 Stent Implantations
por: Fröbert, Ole, et al.
Publicado: (2013)

Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata
por: Stolfo, Davide, et al.
Publicado: (2022)

Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
por: Iacoviello, Massimo, et al.
Publicado: (2022)

Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction
por: Uijl, Alicia, et al.
Publicado: (2021)

The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
por: Correale, Michele, et al.
Publicado: (2023)

Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry
por: Kapelios, Chris J, et al.
Publicado: (2021)

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
por: Lund, Lars H., et al.
Publicado: (2021)

Not Every ST-Segment Elevation Is a STEMI
por: Merlo, Andrea C., et al.
Publicado: (2021)

Long‐term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non‐cardiac mortality
por: Shahim, Angiza, et al.
Publicado: (2023)

Discovering Distinct Phenotypical Clusters in Heart Failure Across the Ejection Fraction Spectrum: a Systematic Review
por: Meijs, Claartje, et al.
Publicado: (2023)

Terminating contamination: large-scale search identifies more than 2,000,000 contaminated entries in GenBank
por: Steinegger, Martin, et al.
Publicado: (2020)

Global longitudinal strain is a more reproducible measure of left ventricular function than ejection fraction regardless of echocardiographic training
por: Karlsen, Sigve, et al.
Publicado: (2019)

Evidence for the biogenesis of more than 1,000 novel human microRNAs
por: Friedländer, Marc R, et al.
Publicado: (2014)

Ten-year experience of more than 35,000 orofacial clefts in Africa
por: Conway, Julia C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sb6u721vnqp31bfh7bii849c9i